Imidazopyridines

Results: 56



#Item
31Microsoft Word[removed]

Microsoft Word[removed]

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2012-02-06 11:14:45
32FDA Approved Labeling[removed]3pm NovaDel Pharma Inc. Zolpimist (zolpidem tartrate) Oral Spray New Drug Application NDA[removed], SN 0021

FDA Approved Labeling[removed]3pm NovaDel Pharma Inc. Zolpimist (zolpidem tartrate) Oral Spray New Drug Application NDA[removed], SN 0021

Add to Reading List

Source URL: www.fda.gov

Language: English
33downers  ■ Overview: “Downers” is a name for depressant drugs, known medically as sedative-hypnotics. The group includes a range of chemicals that depress (or slow down) central nervous system

downers ■ Overview: “Downers” is a name for depressant drugs, known medically as sedative-hypnotics. The group includes a range of chemicals that depress (or slow down) central nervous system

Add to Reading List

Source URL: www.doitnow.org

Language: English - Date: 2011-03-07 17:24:01
34HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTERMEZZO® safely and effectively. See full prescribing information for INTERMEZZO. Intermezzo® (zolpidem tartrat

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTERMEZZO® safely and effectively. See full prescribing information for INTERMEZZO. Intermezzo® (zolpidem tartrat

Add to Reading List

Source URL: www.purduepharma.com

Language: English - Date: 2012-05-02 14:15:26
35Kansas Medical Assistance Program  P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2013-06-10 09:30:24
36PharmaCare Newsletter[removed]

PharmaCare Newsletter[removed]

Add to Reading List

Source URL: www.health.gov.bc.ca

Language: English - Date: 2014-07-14 12:19:54
37HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDLUAR safely and effectively. See full prescribing information for EDLUAR. Edluar (zolpidem tartrate) sublingual ta

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDLUAR safely and effectively. See full prescribing information for EDLUAR. Edluar (zolpidem tartrate) sublingual ta

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-05-01 17:26:53
38Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Peripheral and Central Nervous System Drugs Advisory Committee Meeting May 22, 2013 Location: The FDA White Oak Campus, Building

Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Peripheral and Central Nervous System Drugs Advisory Committee Meeting May 22, 2013 Location: The FDA White Oak Campus, Building

Add to Reading List

Source URL: www.fda.gov

Language: English
39HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMBIEN safely and effectively. See full prescribing information for AMBIEN Ambien (zolpidem tartrate) tablets C-IV I

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMBIEN safely and effectively. See full prescribing information for AMBIEN Ambien (zolpidem tartrate) tablets C-IV I

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-04-23 16:05:10
40DQA Phamarcy Newscapsule January - February 2013

DQA Phamarcy Newscapsule January - February 2013

Add to Reading List

Source URL: www.dhs.wisconsin.gov

Language: English - Date: 2013-02-19 14:16:36